Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content


	figure with microscope of cells, fumes

Immune Diseases

Inputs: Partners

For information about partnering with the NIOSH Immune, Dermal & Infectious Diseases Program, contact the Immune, Dermal & Infectious Diseases Program Coordinator . For general information about partnerships with NIOSH, contact the NIOSH Office of Research and Technology Transfer .

Program Council Members


Dr. B. Jean Meade
NIOSH, Health Effects Laboratory Division
1095 Willowdale Road
Morgantown, WV 26508
(304) 285-5809

Dr. Ray Biagini
NIOSH, Division of Applied Research and Technology
4676 Columbia Parkway, Cincinnati OH, 45226
(513) 533-8196

Dr. Paul Siegel
NIOSH, Health Effects Laboratory Division
Allergy and Clinical Immunology Branch
1095 Willowdale Road
Morgantown, WV 26508
(304) 285-5855

Dr. Michael Luster
NIOSH, Health Effects Laboratory Division
1095 Willowdale Road
Morgantown, WV 26508
(304) 285-5940

Dr. Dori Germolec
National Institute of Environmental Health Sciences
79 Alexander Drive
Research Triangle Park, NC 27709
(919) 541-3230


Dr. Gordon Sussman
Department of Medicine, University of Toronto
Toronto, Ontario, Canada M4V1R2
(416) 944-2531

Stakeholders and Customers

The NIOSH Program for Immune, Dermal, & Infectious Diseases collaborates and works closely with a broad spectrum of the Immune, Dermal, & Infectious Diseases community. The stakeholder and customer list is extensive, including industry, labor, academia, government agencies, non-governmental organizations, and professional organizations both domestic and international. These organizations may be research partners, as described in the previous section. They may also be users of our technology and scientific findings, peer reviewers, recipients of research grants and contracts, or sources of equipment, technology, or knowledge for advancing research in the Immune, Dermal, & Infectious Diseases community.

The NIOSH-Stakeholder Joint Workgroup on Skin Notations is part of the of Immune, Dermal, & Infectious Diseases aims to facilitate the evaluation of scientific data for the assignment of skin notations through collaboration between NIOSH scientists and stakeholders with expertise in occupational skin exposures and diseases.

The regular members include representatives from the following: NIOSH, Procter & Gamble Company, National Institute of Environmental Health Sciences, Vanderbilt University, National Park Service - Intermountain Region, and the Cleveland Clinic.

The collaborative efforts intend to: 1) review and evaluate scientific literature identifying the chemical substances of potential toxicity to the skin or systemic effects by route of skin absorption and the relevant occupational exposures; 2) provide input to assigning chemical-specific NIOSH skin notations and the development of scientific documentation based on review findings; 3) explore research needed to fill the knowledge gaps when currently available scientific data are determined to be insufficient to support a decision on notations. To achieve these objectives, the workgroup shall meet regularly, approximately three to four times a year, to conduct the review for pre-determined chemical substances and to develop recommendations. The workgroup shall first focus the effort on chemical substances of priority as determined from data indicating severe health impacts resulting from skin contact or of significant workplace exposures.